# iQIYI, Inc.: Form 20-F for the period ended Dec 31, 2021

- Company: [iQIYI, Inc.](/companies/iq.md) (CIK 1722608)
- Form: 20-F
- Filed: 2022-03-28
- Accepted by EDGAR: Mar 28, 2022, 06:05 ET
- Period: 2021-12-31
- Accession: 0001564590-22-011874
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1722608/000156459022011874/iq-20f_20211231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1722608/000156459022011874/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2021-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2021-01-01 to 2021-12-31 | $4.79bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months, 2021-01-01 to 2021-12-31 | $4.32bn | us-gaap:CostOfGoodsAndServicesSold |
| Research and development | 12 months, 2021-01-01 to 2021-12-31 | $438.6m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2021-01-01 to 2021-12-31 | $741.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2021-01-01 to 2021-12-31 | −$702.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2021-01-01 to 2021-12-31 | $211.8m | us-gaap:InterestExpense |
| Income tax | 12 months, 2021-01-01 to 2021-12-31 | $15.2m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2021-01-01 to 2021-12-31 | −$968.1m | us-gaap:NetIncomeLoss |
| Operating cash flow | 12 months, 2021-01-01 to 2021-12-31 | −$934.0m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2021-01-01 to 2021-12-31 | $41.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2021-12-31 | $470.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2021-12-31 | $1.81bn | us-gaap:AssetsCurrent |
| Total assets | at 2021-12-31 | $6.66bn | us-gaap:Assets |
| Current liabilities | at 2021-12-31 | $3.53bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2021-12-31 | $5.77bn | us-gaap:Liabilities |
| Short-term borrowings | at 2021-12-31 | $646.2m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2021-12-31 | $827.9m | us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1722608/000156459022011874/iq-20f_20211231.htm

Filed Mar 28, 2022.
Source: SEC EDGAR, the filing index for accession 0001564590-22-011874. Last ingested by Listed: Oct 24, 2026, 15:07 ET. No prices; not investment advice.